These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9484275)

  • 1. Axillary dissection. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S22-6. PubMed ID: 9484275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S15-21. PubMed ID: 9484274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast radiotherapy after breast-conserving surgery. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S35-42. PubMed ID: 9484277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes.
    Moore MP; Kinne DW
    Important Adv Oncol; 1996; ():245-50. PubMed ID: 8791140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer: can axillary dissection be restricted to Berg stages 1 and 2? Study of 895 cases].
    Dufour P; Laurent JC; Depadt G; Demaille A
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):171-7. PubMed ID: 2071860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Axillary lymph node dissection in clinically node-positive breast cancer].
    Iwata H; Miura S
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):831-4. PubMed ID: 12478861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma.
    Bafford A; Gadd M; Gu X; Lipsitz S; Golshan M
    Am J Surg; 2010 Sep; 200(3):374-7. PubMed ID: 20409517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S3-8. PubMed ID: 9484272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
    Schrenk P; Shamiyeh A; Wayand W
    Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is axillary lymph node dissection necessary in routine management of breast cancer? No.
    Cady B
    Important Adv Oncol; 1996; ():251-65. PubMed ID: 8791141
    [No Abstract]   [Full Text] [Related]  

  • 19. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.